Test Predicts Which Patients Will Not Respond to Chemotherapy
Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.
Read More
Search Results for: prostate cancer
Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More
BD Plans to Separate Biosciences and Diagnostic Solutions Business
Summary:BD (Becton, Dickinson and Company) announced its plan to separate its Biosciences and...
Read More
Researchers Create Microchips Capable of Disease Detection
Researchers have developed microchips that can identify multiple diseases from a single cough or air sample.
Read More
Personalized Blood Count Could Lead to Early Intervention for Diseases
A new study reveals that personalized setpoints in complete blood count tests could enable earlier of diseases.
Read More